(+)-VINCRISTINE
Gallbladder Adenocarcinoma
Georgetown UniversitySmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Gallbladder Adenocarcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Atezolizumab Georgetown University | Phase 3 | B |
ADH-1 TRIFLUROACETATE University of Nebraska | Phase 1 | CC |
CIS-DIAMMINEDICHLOROPLATINUM II University of Nebraska | Phase 1 | CC |
Same molecule, other indications
(+)-VINCRISTINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →